Ambrosia Biosciences Incis A Privately Held Drug Discovery Company Located In Bouldercoloradothe Company Specializes In Developing Orally Deliveredsmall Molecule Therapies Aimed At Treating Obesity And Other Metabolic Disordersfounded By A Team Reassembled From Array Biopharmawhich Was Part Of Pfizer S Research Siteambrosia Focuses On Creating Innovative Pharmaceutical Products For The Healthcare Industry The Company Provides Biotechnology Services That Concentrate On Discovering And Developing Novel Small Molecule Drugs Targeting Incretins And Class B Gpcrsambrosia Has Secured $16 Million In Funding Through A Series A Financing Roundled By Bvf Partners And Boulder Venturesto Enhance Its Drug Discovery Activities And Laboratory Operationsthe Leadership Team Includes President And Founder Nick Traggis And Executive Chairman Kyle Lefkoffboth Of Whom Bring Extensive Experience In Medicinal Chemistry
